Impact of Combinatorial Histone Modifications on Acetyllysine Recognition by the ATAD2 and ATAD2B Bromodomains

被引:1
|
作者
Phillips, Margaret [1 ,2 ]
Malone, Kiera L. [1 ]
Boyle, Brian W. [1 ]
Montgomery, Cameron [2 ]
Kressy, Isabelle A. [1 ]
Joseph, Faith M. [3 ,4 ]
Bright, Kathleen M. [5 ]
Boyson, Samuel P. [2 ]
Chang, Sunsik [2 ]
Nix, Jay C. [6 ]
Young, Nicolas L. [3 ,4 ]
Jeffers, Victoria [7 ]
Frietze, Seth [5 ]
Glass, Karen C. [1 ,2 ]
机构
[1] Univ Vermont, Larner Coll Med, Dept Pharmacol, Burlington, VT 05405 USA
[2] Albany Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Colchester, VT 05446 USA
[3] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Pharmacol, Houston, TX 77030 USA
[4] Baylor Coll Med, Translat Biol & Mol Med Grad Program, Houston, TX 77030 USA
[5] Univ Vermont, Dept Biomed & Hlth Sci, Burlington, VT 05405 USA
[6] Adv Light Source, Mol Biol Consortium, Berkeley, CA 94720 USA
[7] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA
基金
美国国家卫生研究院;
关键词
CHROMATIN DYNAMICS; ACETYLATION; METHYLATION; PHOSPHORYLATION; VARIANTS; BINDING; H2AX; H3; PROGNOSIS; SERINE-1;
D O I
10.1021/acs.jmedchem.4c00210
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The ATPase family AAA(+ )domain containing 2 (ATAD2) protein and its paralog ATAD2B have a C-terminal bromodomain (BRD) that functions as a reader of acetylated lysine residues on histone proteins. Using a structure-function approach, we investigated the ability of the ATAD2/B BRDs to select acetylated lysine among multiple histone post-translational modifications. The ATAD2B BRD can bind acetylated histone ligands that also contain adjacent methylation or phosphorylation marks, while the presence of these modifications significantly weakened the acetyllysine binding activity of the ATAD2 BRD. Our structural studies provide mechanistic insights into how ATAD2/B BRD-binding pocket residues coordinate the acetyllysine group in the context of adjacent post-translational modifications. Furthermore, we investigated how sequence changes in amino acids of the histone ligands impact the recognition of an adjacent acetyllysine residue. Our study highlights how the interplay between multiple combinations of histone modifications influences the reader activity of the ATAD2/B BRDs, resulting in distinct binding modes.
引用
收藏
页码:8186 / 8200
页数:15
相关论文
共 43 条
  • [1] Coordination of Di-Acetylated Histone Ligands by the ATAD2 Bromodomain
    Evans, Chiara M.
    Phillips, Margaret
    Malone, Kiera L.
    Tonelli, Marco
    Cornilescu, Gabriel
    Cornilescu, Claudia
    Holton, Simon J.
    Gorjanacz, Matyas
    Wang, Liping
    Carlson, Samuel
    Gay, Jamie C.
    Nix, Jay C.
    Demeler, Borries
    Markley, John L.
    Glass, Karen C.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (17)
  • [2] Structural Insights into the Recognition of Mono- and Diacetylated Histones by the ATAD2B Bromodomain
    Lloyd, Jonathan T.
    McLaughlin, Kyle
    Lubula, Mulu Y.
    Gay, Jamie C.
    Dest, Andrea
    Gao, Cong
    Phillips, Margaret
    Tonelli, Marco
    Cornilescu, Gabriel
    Marunde, Matthew R.
    Evans, Chiara M.
    Boyson, Samuel P.
    Carlson, Samuel
    Keogh, Michael-Christopher
    Markley, John L.
    Frietze, Seth
    Glass, Karen C.
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (21) : 12799 - 12813
  • [3] ATAD2 is an epigenetic reader of newly synthesized histone marks during DNA replication
    Koo, Seong Joo
    Fernandez-Montalvan, Amaury E.
    Badock, Volker
    Ott, Christopher J.
    Holton, Simon J.
    von Ahsen, Oliver
    Toedling, Joern
    Vittori, Sarah
    Bradner, James E.
    Gorjanacz, Matyas
    ONCOTARGET, 2016, 7 (43) : 70323 - 70335
  • [4] ATAD2 overexpression is associated with progression and prognosis in colorectal cancer
    Hou, Mingming
    Huang, Rui
    Song, Yanni
    Feng, Di
    Jiang, Yang
    Liu, Ming
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (03) : 222 - 227
  • [5] Emerging oncogene ATAD2: Signaling cascades and therapeutic initiatives
    Nayak, Aditi
    Dutta, Madhuri
    Roychowdhury, Anasuya
    LIFE SCIENCES, 2021, 276
  • [6] Hitting a Moving Target: Simulation and Crystallography Study of ATAD2 Bromodomain Blockers
    Dolbois, Aymeric
    Batiste, Laurent
    Wiedmer, Lars
    Dong, Jing
    Brutsch, Manuela
    Huang, Danzhi
    Deerain, Nicholas M.
    Spiliotopoulos, Dimitrios
    Cheng-Sanchez, Ivan
    Laul, Eleen
    Nevado, Cristina
    Sledz, Pawel
    Caflisch, Amedeo
    ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (08): : 1573 - 1580
  • [7] ATAD2 is Highly Expressed in Ovarian Carcinomas and Indicates Poor Prognosis
    Wan, Wei-Na
    Zhang, Yi-Xia
    Wang, Xue-Mei
    Liu, Yan-Jun
    Zhang, Yu-Qin
    Que, Yan-Hong
    Zhao, Wen-Jing
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (06) : 2777 - 2783
  • [8] ATAD2 Is a Novel Cofactor for MYC, Overexpressed and Amplified in Aggressive Tumors
    Ciro, Marco
    Prosperini, Elena
    Quarto, Micaela
    Grazini, Ursula
    Walfridsson, Julian
    McBlane, Fraser
    Nucifero, Paolo
    Pacchiana, Giovanni
    Capra, Maria
    Christensen, Jesper
    Helin, Kristian
    CANCER RESEARCH, 2009, 69 (21) : 8491 - 8498
  • [9] ATAD2 predicts poor outcomes in patients with ovarian cancer and is a marker of proliferation
    Liu, Qun
    Liu, Heshu
    Li, Lina
    Dong, Xiaomei
    Ru, Xiaoli
    Fan, Xiana
    Wen, Tao
    Liu, Jian
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2020, 56 (01) : 219 - 231
  • [10] ATAD2 as a Poor Prognostic Marker for Hepatocellular Carcinoma after Curative Resection
    Hwang, Hye Won
    Ha, Sang Yun
    Bang, Heejin
    Park, Cheol-Keun
    CANCER RESEARCH AND TREATMENT, 2015, 47 (04): : 853 - 861